Yield10 Bioscience
YTEN
#10508
Rank
S$0.44 M
Marketcap
S$0.43
Share price
0.00%
Change (1 day)
-82.11%
Change (1 year)
Categories

Earnings for Yield10 Bioscience (YTEN)

Earnings in 2024 (TTM): -S$17.13 Million

According to Yield10 Bioscience's latest financial reports the company's current earnings are S$0.81 Million. In 2023 the company made an earning of -S$18.49 Million a decrease over its 2022 earnings that were of -S$17.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Yield10 Bioscience from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$17.13 Million-7.4%
2023 -S$18.49 Million7.79%
2022 -S$17.16 Million21.96%
2021 -S$14.07 Million8.33%
2020 -S$12.99 Million-23.16%
2019 -S$16.9 Million43.85%
2018 -S$11.75 Million-2.27%
2017 -S$12.02 Million-8.65%
2016 -S$13.16 Million-50.87%
2015 -S$26.79 Million-21.78%
2014 -S$34.24 Million-10.01%
2013 -S$38.06 Million-919.48%
2012 S$4.64 M-109.35%
2011 -S$49.66 Million-0.31%
2010 -S$49.81 Million0.54%
2009 -S$49.54 Million-0.42%
2008 -S$49.75 Million15.01%
2007 -S$43.26 Million92.96%
2006 -S$22.42 Million149.46%
2005 -S$8.99 Million40.49%
2004 -S$6.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.77 Million-82.99% Bahamas
NRC Health
NRC
S$35.26 M-317.08%๐Ÿ‡บ๐Ÿ‡ธ USA